NO332623B1 - Rotekstrakt av Echinacea angustifolia, fremgangsmate for fremstilling av ekstraktet, anvendelse av ekstraktet og farmasoytisk sammensetning inneholdende ekstraktet. - Google Patents
Rotekstrakt av Echinacea angustifolia, fremgangsmate for fremstilling av ekstraktet, anvendelse av ekstraktet og farmasoytisk sammensetning inneholdende ekstraktet. Download PDFInfo
- Publication number
- NO332623B1 NO332623B1 NO20051084A NO20051084A NO332623B1 NO 332623 B1 NO332623 B1 NO 332623B1 NO 20051084 A NO20051084 A NO 20051084A NO 20051084 A NO20051084 A NO 20051084A NO 332623 B1 NO332623 B1 NO 332623B1
- Authority
- NO
- Norway
- Prior art keywords
- organic solvent
- extract
- water
- mixture
- alcohol
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000008569 process Effects 0.000 title claims abstract description 4
- 244000133098 Echinacea angustifolia Species 0.000 title abstract description 16
- 235000014134 echinacea Nutrition 0.000 title abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 title description 3
- 150000004676 glycans Chemical class 0.000 claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 claims abstract description 20
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 claims abstract description 13
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 17
- 239000003960 organic solvent Substances 0.000 claims description 13
- 239000003791 organic solvent mixture Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 229930182830 galactose Natural products 0.000 claims description 4
- 239000011877 solvent mixture Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002417 nutraceutical Substances 0.000 claims description 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims 1
- 229940107493 echinacea angustifolia root extract Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940064972 echinacea angustifolia extract Drugs 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- 230000007124 immune defense Effects 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
- 229930105110 Cyclosporin A Natural products 0.000 description 3
- 108010036949 Cyclosporine Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000020694 echinacea extract Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108010062580 Concanavalin A Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical class CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000521834 Echinacea pallida Species 0.000 description 1
- 240000004530 Echinacea purpurea Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PSKIOIDCXFHNJA-UHFFFAOYSA-N Sanshool Natural products CC=CC=CC=CCCC=CC=CC(=O)NC(C)C PSKIOIDCXFHNJA-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- -1 alkyl amides Chemical class 0.000 description 1
- SBXYHCVXUCYYJT-UEOYEZOQSA-N alpha-Sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)C SBXYHCVXUCYYJT-UEOYEZOQSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001691A ITMI20021691A1 (it) | 2002-07-30 | 2002-07-30 | Estratti di echinacea angustifolia |
| PCT/EP2003/006921 WO2004014404A1 (en) | 2002-07-30 | 2003-06-30 | Echinacea angustifolia extracts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20051084L NO20051084L (no) | 2005-03-22 |
| NO332623B1 true NO332623B1 (no) | 2012-11-19 |
Family
ID=30130952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051084A NO332623B1 (no) | 2002-07-30 | 2005-02-28 | Rotekstrakt av Echinacea angustifolia, fremgangsmate for fremstilling av ekstraktet, anvendelse av ekstraktet og farmasoytisk sammensetning inneholdende ekstraktet. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6881426B2 (ja) |
| EP (1) | EP1539203B1 (ja) |
| JP (1) | JP4537849B2 (ja) |
| KR (1) | KR101032510B1 (ja) |
| CN (1) | CN1316983C (ja) |
| AT (1) | ATE374036T1 (ja) |
| AU (1) | AU2003249900B2 (ja) |
| BR (1) | BRPI0313082B8 (ja) |
| CA (1) | CA2494088C (ja) |
| DE (1) | DE60316578T2 (ja) |
| DK (1) | DK1539203T3 (ja) |
| ES (1) | ES2293061T3 (ja) |
| HK (1) | HK1079101A1 (ja) |
| IL (1) | IL166557A (ja) |
| IT (1) | ITMI20021691A1 (ja) |
| NO (1) | NO332623B1 (ja) |
| PL (1) | PL204869B1 (ja) |
| PT (1) | PT1539203E (ja) |
| RU (1) | RU2317095C2 (ja) |
| SI (1) | SI1539203T1 (ja) |
| WO (1) | WO2004014404A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491414B2 (en) * | 2005-10-12 | 2009-02-17 | Gaia Herbs, Inc. | Anti-inflammatory substances extracted from Echinacea |
| JP4936507B2 (ja) * | 2006-01-18 | 2012-05-23 | 学校法人近畿大学 | カンカニクジュヨウの抽出物より得られる強壮剤又は強精剤、配糖体化合物及びそれらの用途 |
| US7642062B2 (en) | 2006-12-29 | 2010-01-05 | Avon Products Inc. | Compositions and methods of their use for improving the condition and appearance of skin |
| CN101280025B (zh) * | 2008-05-28 | 2013-06-12 | 白日霞 | 具有抗癌作用的海胆壳多糖提取物及其制备方法 |
| EP2133089A1 (en) * | 2008-06-12 | 2009-12-16 | Indena S.P.A. | Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes |
| ES2393239T3 (es) | 2008-06-05 | 2012-12-19 | Indena S.P.A. | Composiciones para el tratamiento de trastornos del tracto respiratorio superior y síndromes de infuenza |
| JP5850929B2 (ja) | 2010-06-30 | 2016-02-03 | エイボン プロダクツ インコーポレーテッド | Ｍａｇｐ−１に刺激を与えて皮膚の外観を改善する組成物 |
| CA2799083C (en) | 2010-06-30 | 2018-04-24 | Avon Products, Inc. | Use of tiliacora triandra in cosmetics and compositions thereof |
| IT1401141B1 (it) * | 2010-07-26 | 2013-07-12 | Indena Spa | Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico |
| CN104394875B (zh) | 2012-03-14 | 2018-12-04 | Izun制药公司 | 用于治疗疾病的新颖的方法和组合物 |
| CN102716164B (zh) * | 2012-06-28 | 2014-11-12 | 齐鲁动物保健品有限公司 | 一种紫锥菊提取物及其制备方法 |
| ITMI20121727A1 (it) | 2012-10-12 | 2014-04-13 | Indena Spa | Formulazioni per il trattamento e la prevenzione dell'obesita' |
| US8920855B1 (en) | 2012-10-30 | 2014-12-30 | Setem Hemth, Inc | Methods of topically treating tinnitus and related disorders |
| CN106176360A (zh) * | 2016-07-26 | 2016-12-07 | 广州众上投资控股集团有限公司 | 一种含有睡莲花萃取物、雪莲花萃取物和狭叶松果菊花萃取物的花蜜霜及其制备方法 |
| RU2635373C1 (ru) * | 2016-08-25 | 2017-11-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Биологически активная добавка для повышения общей работоспособности |
| IT201900001405A1 (it) * | 2019-01-31 | 2020-07-31 | Unifarco S P A | Estratto di echinacea pallida, relativo processo di preparazione, e relative composizioni farmaceutiche, cosmetiche e nutraceutiche |
| CN112315935A (zh) * | 2020-11-30 | 2021-02-05 | 建昌帮药业有限公司 | 一种含有松果菊苷的单层渗透泵控释片及其制备方法 |
| KR102478769B1 (ko) * | 2022-05-31 | 2022-12-20 | 한국콜마주식회사 | 에키네시아 추출물을 포함하는 피부 개선용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3217214A1 (de) | 1982-05-07 | 1983-11-10 | Wagner, Hildebert, Prof. Dr., 8211 Breitbrunn | Polysaccharide aus pflanzen der compositen-familie, verfahren zu ihrer gewinnung und sie enthaltende pharmazeutische zubereitungen |
| DE3541945A1 (de) | 1985-11-27 | 1987-06-04 | Lomapharm Rudolf Lohman Gmbh K | Immunstimulierend wirkende polysaccharide aus zellkulturen von echinacea purpurea (l.) moench und echinacea angustifolia, d.c. verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen |
| US6355684B1 (en) | 1990-10-11 | 2002-03-12 | Meryl J. Squires | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| US5770217A (en) | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
| JP2001078717A (ja) * | 1999-09-17 | 2001-03-27 | Fancl Corp | 食品組成物 |
| PT1220680E (pt) | 1999-09-30 | 2008-06-25 | Factors R & D Technologies Ltd | Suplemento de echinacea e método de fabrico |
| JP2002012546A (ja) * | 2000-06-29 | 2002-01-15 | Noevir Co Ltd | 皮膚外用剤 |
-
2002
- 2002-07-30 IT IT2002MI001691A patent/ITMI20021691A1/it unknown
- 2002-11-25 US US10/302,842 patent/US6881426B2/en not_active Expired - Lifetime
-
2003
- 2003-06-30 PT PT03783996T patent/PT1539203E/pt unknown
- 2003-06-30 SI SI200330999T patent/SI1539203T1/sl unknown
- 2003-06-30 BR BRPI0313082A patent/BRPI0313082B8/pt not_active IP Right Cessation
- 2003-06-30 RU RU2005102103/15A patent/RU2317095C2/ru active
- 2003-06-30 JP JP2004526710A patent/JP4537849B2/ja not_active Expired - Fee Related
- 2003-06-30 ES ES03783996T patent/ES2293061T3/es not_active Expired - Lifetime
- 2003-06-30 EP EP03783996A patent/EP1539203B1/en not_active Expired - Lifetime
- 2003-06-30 DK DK03783996T patent/DK1539203T3/da active
- 2003-06-30 DE DE60316578T patent/DE60316578T2/de not_active Expired - Lifetime
- 2003-06-30 CN CNB038180618A patent/CN1316983C/zh not_active Expired - Fee Related
- 2003-06-30 AT AT03783996T patent/ATE374036T1/de active
- 2003-06-30 AU AU2003249900A patent/AU2003249900B2/en not_active Ceased
- 2003-06-30 PL PL373237A patent/PL204869B1/pl unknown
- 2003-06-30 KR KR1020057001425A patent/KR101032510B1/ko active IP Right Grant
- 2003-06-30 CA CA2494088A patent/CA2494088C/en not_active Expired - Lifetime
- 2003-06-30 WO PCT/EP2003/006921 patent/WO2004014404A1/en active IP Right Grant
-
2005
- 2005-01-31 IL IL166557A patent/IL166557A/en active IP Right Grant
- 2005-02-28 NO NO20051084A patent/NO332623B1/no not_active IP Right Cessation
- 2005-12-06 HK HK05111116A patent/HK1079101A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO332623B1 (no) | Rotekstrakt av Echinacea angustifolia, fremgangsmate for fremstilling av ekstraktet, anvendelse av ekstraktet og farmasoytisk sammensetning inneholdende ekstraktet. | |
| Wang et al. | Structural characterization and antioxidant activities of a novel fructan from Achyranthes bidentata Blume, a famous medicinal plant in China | |
| Wang et al. | Purification, structural characterization and in vivo immunoregulatory activity of a novel polysaccharide from Polygonatum sibiricum | |
| Shi et al. | Structural characterization and antineuroinflammatory activity of a novel heteropolysaccharide obtained from the fruits of Alpinia oxyphylla | |
| Zhang et al. | Isolation and structure elucidation of polysaccharides from fruiting bodies of mushroom Coriolus versicolor and evaluation of their immunomodulatory effects | |
| Olafsdottir et al. | Polysaccharides from lichens: structural characteristics and biological activity | |
| NO333509B1 (no) | Polysakkarid fra Echinacea angustifoliarotter, fremgangsmate ved fremstilling derav, polysakkarid fra Echinacea angustifolia somkan bli fremstilt ved fremgangsmaten, polysakkarid av nevnte type for anvendelse som etmedikament, og farmasoytisk og ernaeringssammensetning samt matvaresupplementsom inneholder polysakkaridet | |
| Wu et al. | Characterization of an arabinogalactan from the fruit hulls of Ficus pumila Linn. and its immunomodulatory effect | |
| Zhang et al. | Immunomodulating polysaccharides from Lessertia frutescens leaves: isolation, characterization and structure activity relationship | |
| Mzoughi et al. | Pectic polysaccharides from edible halophytes: Insight on extraction processes, structural characterizations and immunomodulatory potentials | |
| Wang et al. | Structural characteristics and in vitro and in vivo immunoregulatory properties of a gluco-arabinan from Angelica dahurica | |
| Huang et al. | Preparation, structural elucidation and immunomodulatory activity of a polysaccharide from Millettia Speciosa Champ | |
| Xie et al. | Structural characterization and anti-inflammatory activity of neutral polysaccharides from American ginseng | |
| Wang et al. | Structural characterization and anti-oxidant activity of polysaccharide HVP-1 from Volvariella volvacea | |
| Lv et al. | Structural characterization and immunomodulatory activity of a water-soluble polysaccharide from Poria cocos | |
| Feng et al. | Characterization of the structure, anti-inflammatory activity and molecular docking of a neutral polysaccharide separated from American ginseng berries | |
| Jamtsho et al. | 19Auricularia auricula-judae (Bull.): Major Bioactive Compounds, Health Benefits, and Pharmacological Activities | |
| Zhang et al. | Structural analysis, anti-inflammatory activity of the main water-soluble acidic polysaccharides (AGBP-A3) from Panax quinquefolius L berry | |
| Nie et al. | Beta-glucan from Lentinus, Cordyceps, and Ganoderma | |
| Shen et al. | The Isolation, Structural Characterization and Anti-Inflammatory Potentials of Neutral Polysaccharides from the Roots of Isatis indigotica Fort. | |
| Ruthes et al. | Polysaccharides present in cultivated Teloschistes flavicans symbiosis: Comparison with those of the thallus | |
| Yu et al. | Structural identification and anti-neuroinflammatory effect of a heteropolysaccharide ATP50-3 from Acorus tatarinowii rhizome | |
| Yang et al. | Structural identification and anti-neuroinflammatory effects of a pectin–arabinoglucuronogalactan complex, AOPB-1-1, isolated from Asparagus officinalis | |
| Boustie et al. | Lichen extracts and cancer. | |
| NIKAIDO | ZHONGHUAJIA*, KAZUO KOIKE", NIRANJAN P. SAHU" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |